Clinical Trial Update: A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of TQ05105 for chronic graft-versus-host disease, with the trial currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• TQ05105

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Graft Versus Host Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING